AstraZeneca Drops Suit After Teva Nixes Generic Faslodex
A Delaware federal judge dismissed AstraZeneca Pharmaceuticals LP's patent suit against Teva Pharmaceuticals USA Inc. on Thursday, after Teva withdrew its application to make a generic version of AstraZeneca's breast cancer...To view the full article, register now.
Already a subscriber? Click here to view full article